JP2018531967A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531967A5 JP2018531967A5 JP2018521655A JP2018521655A JP2018531967A5 JP 2018531967 A5 JP2018531967 A5 JP 2018531967A5 JP 2018521655 A JP2018521655 A JP 2018521655A JP 2018521655 A JP2018521655 A JP 2018521655A JP 2018531967 A5 JP2018531967 A5 JP 2018531967A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- disease
- compound
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 201000010099 disease Diseases 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 5
- 206010002023 Amyloidosis Diseases 0.000 claims 3
- 206010002022 Amyloidosis Diseases 0.000 claims 3
- 102000004965 antibodies Human genes 0.000 claims 2
- 108090001123 antibodies Proteins 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 206010001897 Alzheimer's disease Diseases 0.000 claims 1
- 208000001072 Type 2 Diabetes Mellitus Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
Claims (12)
- 結晶形態である、請求項1に記載の化合物。
- 治療上有効な量の請求項1または請求項2に記載の化合物と、薬学上許容可能な賦形剤とを含んでなる、医薬組成物。
- 経口投与のための、請求項3に記載の医薬組成物。
- 抗SAP抗体の1以上の投与形と、請求項1〜4のいずれか一項に記載の化合物または医薬組成物の1以上の投与形とを含んでなる、パーツのキット。
- 請求項1または2に記載の化合物を含んでなる、医薬組成物。
- SAP枯渇において使用するための、請求項6に記載の医薬組成物。
- SAP枯渇が有益である疾患または障害の処置において使用するための、請求項6に記載の医薬組成物。
- 前記疾患または障害が、アミロイドーシス、アルツハイマー病、2型糖尿病および骨関節炎からなる群から選択される、請求項8に記載の医薬組成物。
- 前記疾患または障害がアミロイドーシスである、請求項8に記載の医薬組成物。
- 前記疾患または障害が全身性アミロイドーシスである、請求項8に記載の医薬組成物。
- 抗SAP抗体と組み合わせて用いるための、請求項10または11に記載の医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1518950.9 | 2015-10-27 | ||
GBGB1518950.9A GB201518950D0 (en) | 2015-10-27 | 2015-10-27 | Compound |
PCT/EP2016/075632 WO2017072099A1 (en) | 2015-10-27 | 2016-10-25 | D-proline derivatives as sap depleting agent |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020182835A Division JP7053762B2 (ja) | 2015-10-27 | 2020-10-30 | Sap枯渇剤としてのd-プロリン誘導体 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018531967A JP2018531967A (ja) | 2018-11-01 |
JP2018531967A5 true JP2018531967A5 (ja) | 2019-12-05 |
JP6789288B2 JP6789288B2 (ja) | 2020-11-25 |
Family
ID=55130261
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018521655A Active JP6789288B2 (ja) | 2015-10-27 | 2016-10-25 | Sap枯渇剤としてのd−プロリン誘導体 |
JP2020182835A Active JP7053762B2 (ja) | 2015-10-27 | 2020-10-30 | Sap枯渇剤としてのd-プロリン誘導体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020182835A Active JP7053762B2 (ja) | 2015-10-27 | 2020-10-30 | Sap枯渇剤としてのd-プロリン誘導体 |
Country Status (12)
Country | Link |
---|---|
US (1) | US10328052B2 (ja) |
EP (1) | EP3368532B1 (ja) |
JP (2) | JP6789288B2 (ja) |
KR (1) | KR20180067559A (ja) |
CN (1) | CN108368095B (ja) |
AU (1) | AU2016345462A1 (ja) |
BR (1) | BR112018008582A2 (ja) |
CA (1) | CA3002710A1 (ja) |
ES (1) | ES2781550T3 (ja) |
GB (1) | GB201518950D0 (ja) |
RU (1) | RU2018119120A (ja) |
WO (1) | WO2017072099A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB202111866D0 (en) | 2021-08-18 | 2021-09-29 | Ucl Business Plc | Prodrugs for use in the treatment of tissue damage |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
ATE224366T1 (de) * | 1997-10-31 | 2002-10-15 | Hoffmann La Roche | D-prolinderivate |
US6903129B2 (en) | 2001-12-14 | 2005-06-07 | Hoffman-La Roche Inc. | D-proline prodrugs |
US7265140B2 (en) | 2003-09-23 | 2007-09-04 | Pfizer Inc | Acyloxymethylcarbamate prodrugs of oxazolidinones |
US8236792B2 (en) * | 2008-05-23 | 2012-08-07 | Janssen Pharmaceutica Nv | Substituted pyrrolidine amides as modulators of the histamine H3 receptor |
GB201407506D0 (en) | 2014-04-29 | 2014-06-11 | Glaxosmithkline Ip Dev Ltd | Novel compound |
US9737505B2 (en) | 2014-04-29 | 2017-08-22 | Glaxosmithkline Intellectual Property Development Limited | Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline |
-
2015
- 2015-10-27 GB GBGB1518950.9A patent/GB201518950D0/en not_active Ceased
-
2016
- 2016-10-25 CA CA3002710A patent/CA3002710A1/en not_active Abandoned
- 2016-10-25 JP JP2018521655A patent/JP6789288B2/ja active Active
- 2016-10-25 WO PCT/EP2016/075632 patent/WO2017072099A1/en active Application Filing
- 2016-10-25 ES ES16823162T patent/ES2781550T3/es active Active
- 2016-10-25 KR KR1020187011871A patent/KR20180067559A/ko unknown
- 2016-10-25 US US15/771,442 patent/US10328052B2/en active Active
- 2016-10-25 RU RU2018119120A patent/RU2018119120A/ru not_active Application Discontinuation
- 2016-10-25 AU AU2016345462A patent/AU2016345462A1/en not_active Abandoned
- 2016-10-25 CN CN201680073108.0A patent/CN108368095B/zh active Active
- 2016-10-25 EP EP16823162.9A patent/EP3368532B1/en active Active
- 2016-10-25 BR BR112018008582A patent/BR112018008582A2/pt not_active Application Discontinuation
-
2020
- 2020-10-30 JP JP2020182835A patent/JP7053762B2/ja active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017509667A5 (ja) | ||
JP2016518337A5 (ja) | ||
JP2014507446A5 (ja) | ||
JP2017075173A5 (ja) | ||
JP2013525444A5 (ja) | ||
JP2017149726A5 (ja) | ||
JP2017048208A5 (ja) | ||
JP2016185995A5 (ja) | ||
JP2019516735A5 (ja) | ||
JP2013505205A5 (ja) | ||
JP2015187156A5 (ja) | ||
JP2016515522A5 (ja) | ||
JP2015501783A5 (ja) | ||
JP2015057451A5 (ja) | ||
JP2015212268A5 (ja) | ||
RU2017105353A (ru) | Соединения | |
EA201691454A1 (ru) | Композиции придопидина модифицированного высвобождения | |
JP2015110588A5 (ja) | ||
JP2019529514A5 (ja) | ||
JP2012193216A5 (ja) | ||
JP2015530399A5 (ja) | ||
JP2016510326A5 (ja) | ||
EA201791067A1 (ru) | Способы лечения субъектов с синдромом прадера-вилли или синдромом смита-магениса | |
CY1124115T1 (el) | Η χρηση τριβενζοϊκου γλυκερυλιου που περιεχει συνθεση σε νευροεκφυλιστικες διαταραχες | |
JP2016512817A5 (ja) |